ABSTRACT A serum-free, hormone-supplemented medium, enriched with amixture oflipids, has been developed that supports rapid clonal growth of human diploid fetal lung fibroblasts (Flow 2000, WI-38, MRC-5, and IMR-90) and of low-passage human foreskdn fibroblasts. The medium, which contains less than 1 gg of total protein per ml, also supports serial passage ofFlow 2000 cells under totally serum-free conditions. It provides lipid at a total of 10 pug/ml as a liposome prepared from a mixture of soybean lecithin, cholesterol, sphingomyelin, vitamin E, and vitamin E acetate. The soybean lecithin, which contains a variety of naturally occurring phospholipids, can be replaced with a mixture of highly purified phospholipids. Except for possible contaminants in the substances used in its preparation, the serum-free medium is fully defined chemically. It consists of an optimized basal nutrient medium, MCDB 110, supplemented with insulin, epidermal growth factor, dexamethasone, prostaglandins EI and F2,, phosphoenolpyruvate, dithiothreitol, glutathione, and the lipids listed above.
Rapid clonal growth of normal human diploid cells without serum or other undefined additives has not previously been achieved. In our laboratory, qualitative and quantitative optimization of culture media and improved culture methods have greatly reduced the amount of serum needed for clonal growth of normal human fibroblasts (1-3) and keratinocytes (4) . Sato and coworkers have obtained rapid multiplication of many cell types in conventional media by replacing serum with hormones, growth factors, carrier proteins, and additional nutrients (5) (6) (7) .
Neither of these two approaches alone is fully satisfactory for human diploid fibroblasts (HDF). However, a combination of optimized media plus hormones and growth factors supports significant multiplication of HDF (8) (9) (10) (11) and normal human glial cells (12) . This communication describes additional supplementation to yield a "defined" medium in which the rate of clonal growth of HDF approaches that obtained with serum.
MATERIALS AND METHODS Media and Solutions. Medium MCDB 110 is the same as MCDB 104 (1) except for the following changes: linoleic acid is deleted; glycine is increased from 0.1 to 0.3 mM; KCl is increased from 3.0 to 5.0 mM; Hepes is reduced from 50 to 30 mM; NaCl is increased from 100 to 112 mM; and NaOH added to bring the pH in air at room temperature to 7.65 is reduced from ca. 26 mM to ca. 20 mM. MCDB 110 is used with 2% CO2 rather than 5%. The molar composition of MCDB 110 is given in Table 1 . MCDB 108 (10) Supplement P4 is identical to supplement B except that the commerical grade lecithin at 6 ,ug/ml is replaced by highly purified L-a-phosphatidylcholine (Sigma, P 6263), L-a-phosphatidylethanolamine (Sigma P 4513), L-a-phosphatidylinositol (Sigma P 0639), and dipalmitoyl L-a-phosphatidic acid (sodium salt) (Sigma P 4013) at 1.5 ,ug/ml each. Supplement P-2 has highly purified phosphatidylcholine and phosphatidylethano- 
Pyridoxine HCl Riboflavin Thiamin HCl Vitamin B-12 lamine at 3 ,ug/ml each. Supplement P-1 has highly purified phosphatidylcholine at 6 gg/ml. Supplement C is prepared as follows: (i) dissolve dexamethasone in absolute ethanol at 2 mg/ml; (ii) dissolve insulin in 12 mM HCl at a concentration of 9.5 mg/84 ml; (iii) add 1.0 ml of the dexamethasone solution per 84 ml of the insulin solution, sterilize by filtration, and store frozen; (iv) reconstitute sterile lyophilized EGF in sterile solution A at 20 ,ug/ml and store frozen; (v) mix 8.5 ml of the insulin/dexamethasone solution with 1.5 Trypsinization. Trypsinization is done by the previously described low-temperature method (1, 15) , with the added modification that the partially loosened cellular monolayer is washed with 10 ml ofsolution A to remove excess trypsin while the cells are still attached to the culture surface.
Clonal Growth Assay. Clonal growth experiments are done in 60-mm-diameter plastic tissue culture dishes (Lux 5220) coated with polylysine as described (1, 16) . Supplements A, B, and C are added separately to 5.0 ml of medium in each dish, which is then equilibrated for 1 hr at 37°C in the 2% CO2 incubator before inoculation.
Cells are depleted of serum before use in a serum-free assay. Frozen cells are thawed, placed in MCDB 110 with FBSP at 5 mg/ml for 24 hr, and then into MCDB 110 with FBSP at 1 mg/ml. Prior to confluency, they are trypsinized by the lowtemperature method and split 1:2 into MCDB 110 plus FBSP at 1 mg/ml. After 1 day, the medium is replaced with MCDB 110 plus FBSP at 50 gg/ml for 12-24 hr and then with unsup- When added singly, only supplement CO has any substantial effect. With C0 present, however, supplement B becomes highly stimulatory. Supplement AO is also stimulatory, but only with C0 and B present. The three supplements together support clonal growth that is over 60% (based on total colony area per dish) of the maximum obtainable with an optimal amount of dialyzed serum (FBSP at 1 mg/ml). These results illustrate well the principle that the first limiting factor must be supplied before a response to the next most limiting factor can be observed (3). plement B is preferable to supplement P4. Deletion of cholesterol or sphingomyelin from supplement B reduces clonal growth substantially ( Table 4 ). Deletion of vitamin E and vitamin E acetate increases variability from one experiment to another and usually results in a slight decrease in clonal growth (data not shown). Titration of complete supplement B in the serum-free medium indicates that a total lipid concentration of 10 ug/ml is optimal (Table 4) .
Titration ofthe components of supplement C0 has confirmed earlier observations made in less complete media (8, 10) ofmajor growth responses to EGF and insulin and a minor response to dexamethasone (data not shown). The optimum ranges are broad enough to allow the total protein content of the serumfree medium to be reduced below 1.0 iug/ml without affecting the overall growth response.
Replacement ofserum by supplements A, B, and C requires an optimized basal medium. Essentially no growth is obtained when commercially prepared Dulbecco's modified Eagle's medium (DME), F12, or a 50:50 mixture of DME and F12 is used in place of MCDB 110. Medium MCDB 104 (1), freshly prepared in our laboratory and used with 5% CO2 incubation, supports clonal growth of Flow 2000 cells with supplements A, B, and C. Commercially prepared dry powder MCDB 104 (custom order from GIBCO, kindly supplied to us by Paul Phillips) also works well, but only when supplemented with 5 AM freshly dissolved ferrous sulfate in addition to supplements A, B, and C. Similar results were also obtained in earlier studies involving only supplement C0 (10). (20) , Puck (21) , and others, has been reviewed in detail elsewhere (2, 3, 17, 22, 23) .
Supplement C symbolizes replacement of serum with hormones, growth factors, carrier proteins, and additional nutrients. This approach, pioneered by Sato and coworkers, works well for permanent lines (5-7) and some normal cells (24, 25) but is not effective alone for HDF. However, when combined with optimized medium and techniques, it yields significant growth of HDF (8) (9) (10) (11) (27, 28) . Yamane et al. (33) use bovine serum albumin as a lipid carrier in a "serum-free" medium that supports excellent long-term growth of HDF but is less defined than our medium, due to its high concentration of albumin (5 mg/ml).
Possible effects of vitamin E on cultured cells remain controversial (34) . Free vitamin E is added to supplement B as an antioxidant, and vitamin E acetate is included as a stable form that is inert until it is hydrolyzed after entering the cell.
Supplement A symbolizes the beginning of a long process of "fine tuning" of the defined medium culture system for HDF.
Prostaglandins El and F2,, which are its most active components, have previously been found beneficial in a number of culture systems (7, 22) , including our own preliminary studies with small amounts of FBSP (35) . The other three components ofsupplement A all appear to be marginally beneficial. Because our laboratory is at an altitude of 1650 meters, with reduced oxygen tension relative to sea level, the slight effects ofreducing agents that we observe here may become more significant at lower altitudes.
We anticipate that additional growth requirements for HDF in defined media will be identified in the future. For example, Phillips and Cristofalo (9, 11) have reported that platelet-derived growth factor is needed for monolayer density equivalent Cell Biology: Bettger et aL 5592 Cell Biology: Bettger et aL to that obtained with serum. Preliminary studies in our laboratory have shown that purified platelet-derived growth factor (kindly supplied by Bengt Westermark) increases cellular density within individual colonies of HDF when added to the defined medium on day 7 of a 12-day clonal growth assay.
Many other studies remain to be done on growth of HDF in the defined medium, including further quantitative optimization, an evaluation of the possible role of contaminants, and precise identification of the multiplication-promoting substances in serum that have been replaced by specific components ofthe defined medium, However, the need for such studies does not lessen the significance ofreliable and reproducible growth of normal human cells in a medium that contains no deliberately added undefined substances. The principles that led to development of the defined medium for HDF can now be applied with confidence to other cell types. Approaches similar to those described here have already resulted in clonal growth in defined media ofhuman epidermal keratinocytes (36) and rabbit ear chondrocytes (37) .
